LPL Financial
BLPH

LPL Financial’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

LPL Financial’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,080
Closed -$67K – 4209
2020
Q4 		$67K Buy
+10,080
New +$82.5K ﹤0.01% 3716
2020
Q3 		– Sell
-10,413
Closed -$131K – 3692
2020
Q2 		$131K Buy
+10,413
New +$146K ﹤0.01% 3248
2020
Q1 		– Sell
-9,220
Closed -$48K – 3511
2019
Q4 		$48K Hold
9,220
– – ﹤0.01% 3278
2019
Q3 		$67K Buy
9,220
+500
+6% +$4.56K ﹤0.01% 3188
2019
Q2 		$78K Buy
8,720
+1,577
+22% +$15.1K ﹤0.01% 3174
2019
Q1 		$70K Buy
7,143
+980
+16% +$10.8K ﹤0.01% 3096
2018
Q4 		$74K Hold
6,163
– – ﹤0.01% 2982
2018
Q3 		$100K Buy
6,163
+1,976
+47% +$46.9K ﹤0.01% 3128
2018
Q2 		$152K Hold
4,187
– – ﹤0.01% 3049
2018
Q1 		$131K Hold
4,187
– – ﹤0.01% 3042
2017
Q4 		$162K Sell
4,187
-133
-3% -$3.49K ﹤0.01% 2861
2017
Q3 		$92K Sell
4,320
-2,019
-32% -$37.5K ﹤0.01% 2781
2017
Q2 		$127K Sell
6,339
-197
-3% -$4.08K ﹤0.01% 2685
2017
Q1 		$150K Buy
6,536
+200
+3% +$3.14K ﹤0.01% 2551
2016
Q4 		$51K Buy
6,336
+1,600
+34% +$22.3K ﹤0.01% 2635
2016
Q3 		$99K Buy
4,736
+1,496
+46% +$36.1K ﹤0.01% 2537
2016
Q2 		$80K Sell
3,240
-843
-21% -$23.1K ﹤0.01% 2531
2016
Q1 		$131K Hold
4,083
– – ﹤0.01% 2902
2015
Q4 		$180K Buy
4,083
+1,831
+81% +$88.7K ﹤0.01% 2861
2015
Q3 		$143K Buy
+2,252
New +$173K ﹤0.01% 2602

Other funds holding BLPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMVA
New Mountain Vantage Advisers New York $4.33B AUM 35.3% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LPL Financial's BLPH Position: Q1 2021 in Review

LPL Financial sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q1 2021, closing a stake of 10,080 shares — an estimated $67K sold.

LPL Financial first reported a position in BLPH in Q3 2015 and held it in 20 quarters. The position peaked at $180K in Q4 2015. 39 funds tracked by Wall St. Rank hold BLPH as of Q1 2021.

  • LPL Financial reported no remaining Bellerophon Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • LPL Financial sold 10,080 Bellerophon Therapeutics, Inc. shares in Q1 2021, an estimated $67K.
  • LPL Financial first reported a position in Bellerophon Therapeutics, Inc. in Q3 2015 and held it in 20 quarters.
  • LPL Financial's Bellerophon Therapeutics, Inc. position peaked at $180K in Q4 2015.
  • 39 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q1 2021.

Based on LPL Financial's 13F filing for Q1 2021, filed 14 May 2021.